Regulatory mutations in CHO cells induce expression of the mouse embryonic antigen SSEA-1

Cell
|November 1, 1983
PubMed

Insights

Two Chinese hamster ovary (CHO) cell mutants, LEC11 and LEC12, express the mouse embryonic antigen SSEA-1 due to regulatory mutations affecting fucosyltransferase genes. These mutants show distinct enzyme activities not present in parental cells or revertants.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Genetics

Background:

  • Chinese hamster ovary (CHO) cells are a common model system in biological research.
  • The mouse embryonic antigen SSEA-1 is a key developmental marker.
  • Understanding mutations in cell lines aids in deciphering gene regulation.

Purpose of the Study:

  • To investigate the molecular basis of SSEA-1 expression in CHO cell mutants.
  • To identify the specific enzymatic activities associated with SSEA-1 expression.
  • To explore the genetic regulation of fucosyltransferase genes.

Main Methods:

  • Utilized radioimmunoassay with monoclonal antibodies to detect SSEA-1.
  • Analyzed N-acetylglucosaminide alpha(1,3)fucosyltransferase activities in cell extracts.
  • Compared enzyme substrate specificities and products between mutants and parental cells.

Main Results:

  • LEC11 and LEC12 CHO cell mutants express the SSEA-1 antigen.
  • Parental CHO cells and revertants (LEC11.R9, LEC12.R10) do not express SSEA-1.
  • SSEA-1 expression correlates with the de novo activity of specific N-acetylglucosaminide alpha(1,3)fucosyltransferases.
  • Differences in enzyme substrate specificities and products were observed.

Conclusions:

  • LEC11 and LEC12 mutants likely arise from regulatory mutations.
  • These mutations affect distinct fucosyltransferase genes.
  • The study provides insights into the genetic control of SSEA-1 expression and fucosylation in CHO cells.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...